| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |